de.mpg.escidoc.pubman.appbase.FacesBean
Deutsch
 
Hilfe Wegweiser Datenschutzhinweis Impressum Kontakt
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Vortrag

Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines

MPG-Autoren
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86517

Wolff,  M.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;
Otto-von-Guericke-Universität Magdeburg, External Organizations;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86343

Kalbfuss,  B.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86531

Zimmermann,  A.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Wolff, M., Kalbfuss, B., Morenweiser, R., Zimmermann, A., & Reichl, U. (2005). Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Talk presented at Viral Vectors and Vaccines Conference. Austin, Texas. 2005-11-14 - 2005-11-16.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0013-9B7B-B
Zusammenfassung
The increasing demand for cell culture based production of influenza virus vaccines requires the development of new purification strategies that are adapted to the altered upstream conditions. This workshop presents a modular purification scheme including two chromatography operations for whole-virion purification of human influenza A virus as a model system.